Zaderej Karen L.
SEC insider (Form 3/4/5 filer). CIK 0001530968. Director at EyePoint, Inc. (EYPT). 8 reported Form 4/5 transactions since Sep 2024; latest on Aug 18, 2026. Located in WATERTOWN, MA.
Companies Zaderej Karen L. has filed insider reports for
- EyePoint, Inc. (EYPT): Director
Zaderej Karen L.
CIK: 0001530968
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
EyePoint, Inc.
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Aug 18, 2026EYPT
EyePoint, Inc.
PurchaseDirect10.6K shares at avg. $4.93$52K - Jan 2, 2026EYPT
EyePoint, Inc.
AwardDirectStock Option (Right to Buy)
40K shares- - Jul 11, 2025EYPT
EyePoint Pharmaceuticals, Inc.
ExerciseDirect2K shares- - May 19, 2025EYPT
EyePoint Pharmaceuticals, Inc.
PurchaseDirect5K shares at avg. $5.99$30K - May 16, 2025EYPT
EyePoint Pharmaceuticals, Inc.
PurchaseDirect5K shares at avg. $5.81$29K - May 15, 2025EYPT
EyePoint Pharmaceuticals, Inc.
PurchaseDirect5K shares at avg. $5.47$27K - May 14, 2025EYPT
EyePoint Pharmaceuticals, Inc.
PurchaseDirect5K shares at avg. $5.42$27K - Jan 3, 2025EYPT
EyePoint Pharmaceuticals, Inc.
AwardDirectStock Option (Right to Buy)
40K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 18, 2026 | EYPT EyePoint, Inc. | Purchase | 10,600 | $4.93 | $52,258 | Direct |
| Jan 2, 2026 | EYPT EyePoint, Inc. | Award Stock Option (Right to Buy) | 40,000 | - | - | Direct |
| Jul 11, 2025 | EYPT EyePoint Pharmaceuticals, Inc. | Exercise | 2,000 | - | - | Direct |
| May 19, 2025 | EYPT EyePoint Pharmaceuticals, Inc. | Purchase | 5,000 | $5.99 | $29,950 | Direct |
| May 16, 2025 | EYPT EyePoint Pharmaceuticals, Inc. | Purchase | 5,000 | $5.81 | $29,050 | Direct |
| May 15, 2025 | EYPT EyePoint Pharmaceuticals, Inc. | Purchase | 5,000 | $5.47 | $27,350 | Direct |
| May 14, 2025 | EYPT EyePoint Pharmaceuticals, Inc. | Purchase | 5,000 | $5.42 | $27,100 | Direct |
| Jan 3, 2025 | EYPT EyePoint Pharmaceuticals, Inc. | Award Stock Option (Right to Buy) | 40,000 | - | - | Direct |
1-8 of 8 transactions